Beth Hoffman

Company: Origami Therapeutic

Job title: CEO

Seminars:

Round Table Discussion: Examples of Degraders Entering the CNS 2:00 pm

What E3 ligase was utilised? What does the structure of the PROTAC look like? What are the main challenges of delivering protein degraders across the blood brain barrier and how is this overcome? What are the druggable and undruggable targets within neurodegenerative disease that could be targeted with protein degradation strategies?Read more

day: Day 2 PM - Stream B